- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Jones Healthcare Group Acquires Ontario Thermoforming Facility | ||
| Fr | Biogen Completes RayThera Acquisition | ||
| Fr | AstraZeneca, CSPC Establish New Biologics Manufacturing JV in China | ||
| Do | Mediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases | ||
| Do | CellFiber, Tidewave Bio to Evaluate 3D Cell Culture Platform for Scalable Manufacturing | ||
| Do | Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases | ||
| Do | ILC Dover Shares Testing Results for EZJetFlo for Powder Dissolution and Mixing | ||
| Mi | BMS to Deploy Schrödinger AI Co-Scientist Bunsen in Its Research Organization | ||
| Mi | Porton Advanced Expands CDMO Services to Commercialization with China Manufacturing License | ||
| Mi | NueCell Bio Launches as Specialist Partner in Cell Therapy Acceleration | ||
| Mi | Alteogen Inks Licensing Pact with Global Pharma Company to Develop, Commercialize Subcutaneous Biologic | ||
| Mi | Lilly 2Q Revenues Top $23B | ||
| Di | Lilly, Amplia to Evaluate Combined Investigational Treatments for Advanced NSCLC | ||
| Di | FDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi | ||
| Di | Altasciences Completes R&D Lab Expansion in Pennsylvania | ||
| Di | Supernus and Indivior to Merge, Creating Diversified CNS Biopharma Company | ||
| Di | FUJIFILM Biotechnologies Transitions Leadership | ||
| Di | Johnson & Johnson EVP Jennifer Taubert to Retire, Tom Cavanaugh Named Successor | ||
| Di | Piramal Pharma Solutions Expands Peptide API Facility | ||
| Mo | Niagen Selects Evotec to Advance Preclinical Development of Oral Small-Molecule Candidate | ||
| Mo | Obsidian Therapeutics Completes Galera Therapeutics Merger with $350M Private Placement Financing | ||
| Mo | Plus Therapeutics Rebrands with Launch of Cerenome | ||
| Mo | Curium, Lantheus to Merge in Deal Worth Up to $8B | ||
| Mo | BioNTech Names Guido Oelkers as CEO | ||
| Mo | Codis Completes Acquisition of Catalent's Nottingham, UK Facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.